Ninds advanced cell and gene therapy CMC consulting

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201600040C
Awardee
Awarding agency
Obligated
$12,900

Award facts

Opportunity
Contract value 100% obligated
$12,900.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541690 Other Scientific and Technical Consulting Services
PSC
R499 Support- Professional: Other
Set-aside
No set-aside
Competition
Competed under SAP · 6 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 · CMC consulting development consulting services -$15,100
Exercise an Option 2 $8,000
Exercise an Option 1 $8,000
Original award $12,000

Quick answers

Who was awarded contract HHSN271201600040C?

HHSN271201600040C was awarded to Advanced Cell & Gene Therapy LLC by National Institute on Drug Abuse (National Institutes of Health) on September 14, 2016.

How much is contract HHSN271201600040C worth?

The government has obligated $12,900 on HHSN271201600040C.

Was contract HHSN271201600040C competed?

The extent of competition for HHSN271201600040C was competed under sap. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award